• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重胰岛素抵抗 2 型糖尿病的胰岛素剂量反应研究——高胰岛素剂量有效的证据。

Insulin dose-response studies in severely insulin-resistant type 2 diabetes--evidence for effectiveness of very high insulin doses.

机构信息

Department of Endocrinology and Internal Medicine, NBG/THG, Aarhus University Hospital, Aarhus, Denmark.

出版信息

Diabetes Obes Metab. 2011 Jun;13(6):511-6. doi: 10.1111/j.1463-1326.2011.01373.x.

DOI:10.1111/j.1463-1326.2011.01373.x
PMID:21272188
Abstract

AIM

To combat diabetic complications strict glycaemic control is desirable in type 2 diabetes, but some patients are severely insulin resistant and it is not known whether high doses of insulin are effective. This study was designed to determine the acute dose-response effects of insulin in patients with type 2 diabetes and severe insulin resistance.

METHODS

We included eight insulin-resistant (mean insulin dose: 186 IU/day; body mass index: 35) subjects with type 2 diabetes in a single-blinded, randomized crossover study. Each subject was studied on two occasions. On each occasion, subjects underwent two 3-h hyperinsulinaemic euglycaemic clamps. The subjects were randomized to two low-dose insulin infusions (0.5 and 1.5 mU/kg/min in random order) on one occasion and to two high-dose insulin infusions (3.0 and 5.0 mU/kg/min in random order) on another occasion.

RESULTS

On all occasions, steady-state glucose infusion rates (SSGIRs) were accomplished and we observed a clear dose-response relationship with GIR values of 0.4 ± 0.2 (s.e.), 2.6 ± 0.6, 3.7 ± 0.8 and 4.9 ± 0.9 mg/kg/min during the 0.5, 1.5, 3.0 and 5.0 mU/kg/min insulin infusions, respectively (p < 0.001). Likewise, there was a dose-dependent suppression of endogenous glucose production (EGP) (p < 0.009), plasma free fatty acids (FFAs) (p < 0.001) and plasma glucagon (p = 0.001).

CONCLUSIONS

Our results show that the insulin dose response in terms of GIR and EGP is preserved for insulin doses corresponding to >800 IU/day, suggesting effectiveness of very high insulin doses in severely insulin-resistant subjects.

摘要

目的

在 2 型糖尿病中,严格的血糖控制是理想的,但有些患者存在严重的胰岛素抵抗,尚不清楚高剂量胰岛素是否有效。本研究旨在确定胰岛素在严重胰岛素抵抗的 2 型糖尿病患者中的急性剂量反应效应。

方法

我们将 8 例胰岛素抵抗(平均胰岛素剂量:186IU/天;体重指数:35)的 2 型糖尿病患者纳入单盲、随机交叉研究。每位患者接受两次研究。在每一次研究中,患者都接受了两次 3 小时的高胰岛素-正常血糖钳夹。根据随机顺序,患者在一次研究中接受两种低剂量胰岛素输注(0.5 和 1.5mU/kg/min),在另一次研究中接受两种高剂量胰岛素输注(3.0 和 5.0mU/kg/min)。

结果

在所有情况下,均达到稳态葡萄糖输注率(SSGIR),我们观察到明确的剂量反应关系,GIR 值分别为 0.4±0.2(s.e.)、2.6±0.6、3.7±0.8 和 4.9±0.9mg/kg/min,在 0.5、1.5、3.0 和 5.0mU/kg/min 的胰岛素输注时(p<0.001)。同样,内源性葡萄糖产生(EGP)(p<0.009)、血浆游离脂肪酸(FFA)(p<0.001)和血浆胰高血糖素(p=0.001)也存在剂量依赖性抑制。

结论

我们的结果表明,GIR 和 EGP 的胰岛素剂量反应在对应于>800IU/天的胰岛素剂量下是保留的,这表明非常高剂量胰岛素在严重胰岛素抵抗的患者中是有效的。

相似文献

1
Insulin dose-response studies in severely insulin-resistant type 2 diabetes--evidence for effectiveness of very high insulin doses.严重胰岛素抵抗 2 型糖尿病的胰岛素剂量反应研究——高胰岛素剂量有效的证据。
Diabetes Obes Metab. 2011 Jun;13(6):511-6. doi: 10.1111/j.1463-1326.2011.01373.x.
2
Postprandial insulin secretion pattern is associated with histological severity in non-alcoholic fatty liver disease patients without prior known diabetes mellitus.非酒精性脂肪性肝病患者在未经诊断患有糖尿病之前,餐后胰岛素分泌模式与组织学严重程度相关。
J Gastroenterol Hepatol. 2011 Mar;26(3):517-22. doi: 10.1111/j.1440-1746.2010.06567.x.
3
Troglitazone, an insulin action enhancer, improves glycaemic control and insulin sensitivity in elderly type 2 diabetic patients.曲格列酮作为一种胰岛素作用增强剂,可改善老年2型糖尿病患者的血糖控制及胰岛素敏感性。
Diabet Med. 1998 Sep;15(9):772-9. doi: 10.1002/(SICI)1096-9136(199809)15:9<772::AID-DIA677>3.0.CO;2-X.
4
Insulin therapy in type 2 diabetes.2型糖尿病的胰岛素治疗
Med Clin North Am. 2004 Jul;88(4):865-95, x. doi: 10.1016/j.mcna.2004.04.005.
5
Acute effects of valsartan on insulin sensitivity in obese, non-hypertensive subjects with and without type 2 diabetes.缬沙坦对伴有或不伴有2型糖尿病的肥胖非高血压受试者胰岛素敏感性的急性影响。
Horm Metab Res. 2002 May;34(5):271-4. doi: 10.1055/s-2002-32142.
6
[Insulin treatment is of value--also in type 2 diabetes].胰岛素治疗具有价值——对2型糖尿病患者同样如此。
Tidsskr Nor Laegeforen. 1996 Apr 20;116(10):1233-5.
7
[Combination treatment with insulin and sulfonylurea. Results of a 5-year study].[胰岛素与磺脲类药物联合治疗。一项5年研究的结果]
Z Gesamte Inn Med. 1989 May 1;44(9):261-4.
8
[Comparative effectiveness of the treatment od patients with hyperglycemic coma in diabetes mellitus with small and large doses of insulin].[小剂量和大剂量胰岛素治疗糖尿病高血糖昏迷患者的疗效比较]
Klin Med (Mosk). 1990 Jun;68(6):133-6.
9
Diabetic neuropathy is associated with activation of the TNF-alpha system in subjects with type 1 diabetes mellitus.糖尿病神经病变与1型糖尿病患者体内肿瘤坏死因子-α系统的激活有关。
Clin Endocrinol (Oxf). 2005 Nov;63(5):525-9. doi: 10.1111/j.1365-2265.2005.02376.x.
10
[Role of physical activity in the therapy and prevention of Type II diabetes mellitus].[体育活动在2型糖尿病治疗与预防中的作用]
Ther Umsch. 1996 Dec;53(12):925-33.

引用本文的文献

1
A more holistic view of the logarithmic dose-response curve offers greater insights into insulin responses.对对数剂量反应曲线进行更全面的观察能更深入地了解胰岛素反应。
J Biol Chem. 2025 Jan;301(1):108037. doi: 10.1016/j.jbc.2024.108037. Epub 2024 Nov 29.
2
From waste to wonder: exploring the hypoglycemic and anti-oxidant properties of corn processing by-products.从废物到奇迹:探索玉米加工副产品的降血糖和抗氧化特性。
Front Chem. 2024 Jul 18;12:1433501. doi: 10.3389/fchem.2024.1433501. eCollection 2024.
3
Short-term semaglutide treatment improves FGF21 responsiveness in primary hepatocytes isolated from high fat diet challenged mice.
短期司美格鲁肽治疗可改善高脂肪饮食挑战小鼠原代肝细胞中 FGF21 的反应性。
Physiol Rep. 2023 Mar;11(5):e15620. doi: 10.14814/phy2.15620.
4
LIPODYSTROPHY FREQUENCY ACCORDING TO INSULIN TREATMENT REGIMEN IN TYPE 2 DIABETIC PATIENTS: IS INSULIN INJECTION FREQUENCY MATTERS IN ANALOG INSULIN ERA?2型糖尿病患者中根据胰岛素治疗方案划分的脂肪营养不良发生率:在胰岛素类似物时代胰岛素注射频率重要吗?
Acta Endocrinol (Buchar). 2022 Apr-Jun;18(2):202-208. doi: 10.4183/aeb.2022.202.
5
Human skeletal muscle CD90 fibro-adipogenic progenitors are associated with muscle degeneration in type 2 diabetic patients.人类骨骼肌 CD90 成纤维脂肪祖细胞与 2 型糖尿病患者的肌肉退化有关。
Cell Metab. 2021 Nov 2;33(11):2201-2214.e11. doi: 10.1016/j.cmet.2021.10.001. Epub 2021 Oct 21.
6
Extreme insulin resistance during pregnancy: a therapeutic challenge.妊娠期严重胰岛素抵抗:一项治疗挑战。
Endocrinol Diabetes Metab Case Rep. 2021 Jul 1;2021. doi: 10.1530/EDM-20-0191.
7
Improvement of skeletal muscle insulin sensitivity by 1 week of SGLT2 inhibitor use.使用SGLT2抑制剂1周可改善骨骼肌胰岛素敏感性。
Endocr Connect. 2020 Jul;9(7):599-606. doi: 10.1530/EC-20-0082.
8
Determinants of Maternal Insulin Resistance during Pregnancy: An Updated Overview.妊娠期母体胰岛素抵抗的决定因素:最新综述。
J Diabetes Res. 2019 Nov 19;2019:5320156. doi: 10.1155/2019/5320156. eCollection 2019.
9
Effects of Renal Denervation on Insulin Sensitivity and Inflammatory Markers in Nondiabetic Patients with Treatment-Resistant Hypertension.肾去神经术对治疗抵抗性高血压的非糖尿病患者胰岛素敏感性和炎症标志物的影响。
J Diabetes Res. 2017;2017:6915310. doi: 10.1155/2017/6915310. Epub 2017 Sep 7.
10
Altered gene expression and repressed markers of autophagy in skeletal muscle of insulin resistant patients with type 2 diabetes.2 型糖尿病胰岛素抵抗患者骨骼肌中基因表达改变和自噬标志物受抑制。
Sci Rep. 2017 Mar 2;7:43775. doi: 10.1038/srep43775.